nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0548	0.0809	CbGbCtD
Ipratropium bromide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0515	0.0761	CbGbCtD
Ipratropium bromide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0515	0.0761	CbGbCtD
Ipratropium bromide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0466	0.0688	CbGbCtD
Ipratropium bromide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0466	0.0688	CbGbCtD
Ipratropium bromide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0402	0.0594	CbGbCtD
Ipratropium bromide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.039	0.0576	CbGbCtD
Ipratropium bromide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0353	0.0521	CbGbCtD
Ipratropium bromide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0353	0.0521	CbGbCtD
Ipratropium bromide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0348	0.0514	CbGbCtD
Ipratropium bromide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0327	0.0484	CbGbCtD
Ipratropium bromide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0327	0.0484	CbGbCtD
Ipratropium bromide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0296	0.0437	CbGbCtD
Ipratropium bromide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0296	0.0437	CbGbCtD
Ipratropium bromide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0256	0.0378	CbGbCtD
Ipratropium bromide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0248	0.0367	CbGbCtD
Ipratropium bromide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0224	0.0331	CbGbCtD
Ipratropium bromide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0224	0.0331	CbGbCtD
Ipratropium bromide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0215	0.0318	CbGbCtD
Ipratropium bromide—CHRM5—skin of body—acquired immunodeficiency syndrome	0.00162	0.0597	CbGeAlD
Ipratropium bromide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0382	CbGeAlD
Ipratropium bromide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0376	CbGeAlD
Ipratropium bromide—CHRM5—nervous system—acquired immunodeficiency syndrome	0.001	0.0369	CbGeAlD
Ipratropium bromide—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000966	0.0356	CbGeAlD
Ipratropium bromide—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.000918	0.0338	CbGeAlD
Ipratropium bromide—SLC22A4—blood—acquired immunodeficiency syndrome	0.000875	0.0322	CbGeAlD
Ipratropium bromide—SLC22A5—retina—acquired immunodeficiency syndrome	0.000866	0.0319	CbGeAlD
Ipratropium bromide—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.000847	0.0312	CbGeAlD
Ipratropium bromide—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.000843	0.031	CbGeAlD
Ipratropium bromide—SLC22A4—vagina—acquired immunodeficiency syndrome	0.000811	0.0299	CbGeAlD
Ipratropium bromide—SLC22A4—lung—acquired immunodeficiency syndrome	0.000767	0.0282	CbGeAlD
Ipratropium bromide—CHRM5—brain—acquired immunodeficiency syndrome	0.000767	0.0282	CbGeAlD
Ipratropium bromide—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.00076	0.028	CbGeAlD
Ipratropium bromide—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000725	0.0267	CbGeAlD
Ipratropium bromide—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000689	0.0254	CbGeAlD
Ipratropium bromide—CHRM1—lung—acquired immunodeficiency syndrome	0.000677	0.0249	CbGeAlD
Ipratropium bromide—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000663	0.0244	CbGeAlD
Ipratropium bromide—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000627	0.0231	CbGeAlD
Ipratropium bromide—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000608	0.0224	CbGeAlD
Ipratropium bromide—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000603	0.0222	CbGeAlD
Ipratropium bromide—SLC22A5—blood—acquired immunodeficiency syndrome	0.000579	0.0213	CbGeAlD
Ipratropium bromide—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000561	0.0207	CbGeAlD
Ipratropium bromide—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000558	0.0205	CbGeAlD
Ipratropium bromide—SLC22A4—brain—acquired immunodeficiency syndrome	0.000543	0.02	CbGeAlD
Ipratropium bromide—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00054	0.0199	CbGeAlD
Ipratropium bromide—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000537	0.0198	CbGeAlD
Ipratropium bromide—CHRM2—brain—acquired immunodeficiency syndrome	0.000526	0.0194	CbGeAlD
Ipratropium bromide—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.000525	0.0193	CbGeAlD
Ipratropium bromide—SLC22A5—lung—acquired immunodeficiency syndrome	0.000508	0.0187	CbGeAlD
Ipratropium bromide—CHRM1—brain—acquired immunodeficiency syndrome	0.000479	0.0176	CbGeAlD
Ipratropium bromide—CHRM3—brain—acquired immunodeficiency syndrome	0.000429	0.0158	CbGeAlD
Ipratropium bromide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000399	0.0147	CbGeAlD
Ipratropium bromide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000392	0.0144	CbGeAlD
Ipratropium bromide—CYP3A4—blood—acquired immunodeficiency syndrome	0.00038	0.014	CbGeAlD
Ipratropium bromide—CYP2D6—blood—acquired immunodeficiency syndrome	0.000374	0.0138	CbGeAlD
Ipratropium bromide—SLC22A5—brain—acquired immunodeficiency syndrome	0.000359	0.0132	CbGeAlD
Ipratropium bromide—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000347	0.0128	CbGeAlD
Ipratropium bromide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000308	0.0114	CbGeAlD
Ipratropium bromide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000303	0.0112	CbGeAlD
Ipratropium bromide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000297	0.0109	CbGeAlD
Ipratropium bromide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.000999	CcSEcCtD
Ipratropium bromide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.000996	CcSEcCtD
Ipratropium bromide—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000995	CcSEcCtD
Ipratropium bromide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.000994	CcSEcCtD
Ipratropium bromide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.000994	CcSEcCtD
Ipratropium bromide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000993	CcSEcCtD
Ipratropium bromide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.000991	CcSEcCtD
Ipratropium bromide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.000991	CcSEcCtD
Ipratropium bromide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000293	0.000991	CcSEcCtD
Ipratropium bromide—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.000989	CcSEcCtD
Ipratropium bromide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000292	0.0108	CbGeAlD
Ipratropium bromide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000292	0.000986	CcSEcCtD
Ipratropium bromide—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000291	0.000985	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.000985	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000291	0.000983	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000291	0.000982	CcSEcCtD
Ipratropium bromide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.000981	CcSEcCtD
Ipratropium bromide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000289	0.000977	CcSEcCtD
Ipratropium bromide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000289	0.000977	CcSEcCtD
Ipratropium bromide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.000976	CcSEcCtD
Ipratropium bromide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000289	0.000975	CcSEcCtD
Ipratropium bromide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.000975	CcSEcCtD
Ipratropium bromide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000287	0.000969	CcSEcCtD
Ipratropium bromide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.000968	CcSEcCtD
Ipratropium bromide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000286	0.000968	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000286	0.000968	CcSEcCtD
Ipratropium bromide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000286	0.000968	CcSEcCtD
Ipratropium bromide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.000964	CcSEcCtD
Ipratropium bromide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000285	0.000962	CcSEcCtD
Ipratropium bromide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000284	0.000961	CcSEcCtD
Ipratropium bromide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.00096	CcSEcCtD
Ipratropium bromide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000284	0.000958	CcSEcCtD
Ipratropium bromide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000283	0.000957	CcSEcCtD
Ipratropium bromide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.000953	CcSEcCtD
Ipratropium bromide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.000951	CcSEcCtD
Ipratropium bromide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00095	CcSEcCtD
Ipratropium bromide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000281	0.000949	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.000948	CcSEcCtD
Ipratropium bromide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.000947	CcSEcCtD
Ipratropium bromide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00028	0.000946	CcSEcCtD
Ipratropium bromide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00028	0.000945	CcSEcCtD
Ipratropium bromide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000279	0.000944	CcSEcCtD
Ipratropium bromide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000279	0.000943	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.000942	CcSEcCtD
Ipratropium bromide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00094	CcSEcCtD
Ipratropium bromide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00094	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.000934	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000275	0.000931	CcSEcCtD
Ipratropium bromide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000275	0.00093	CcSEcCtD
Ipratropium bromide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000275	0.000929	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.000928	CcSEcCtD
Ipratropium bromide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.000927	CcSEcCtD
Ipratropium bromide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.000926	CcSEcCtD
Ipratropium bromide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000922	CcSEcCtD
Ipratropium bromide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000922	CcSEcCtD
Ipratropium bromide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.000921	CcSEcCtD
Ipratropium bromide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.000921	CcSEcCtD
Ipratropium bromide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.000919	CcSEcCtD
Ipratropium bromide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.000918	CcSEcCtD
Ipratropium bromide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.000916	CcSEcCtD
Ipratropium bromide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.000915	CcSEcCtD
Ipratropium bromide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.000915	CcSEcCtD
Ipratropium bromide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00027	0.000912	CcSEcCtD
Ipratropium bromide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00027	0.000912	CcSEcCtD
Ipratropium bromide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.000911	CcSEcCtD
Ipratropium bromide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.000908	CcSEcCtD
Ipratropium bromide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.000905	CcSEcCtD
Ipratropium bromide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.000905	CcSEcCtD
Ipratropium bromide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.000905	CcSEcCtD
Ipratropium bromide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.000901	CcSEcCtD
Ipratropium bromide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000266	0.000899	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.000899	CcSEcCtD
Ipratropium bromide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000265	0.000897	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.000888	CcSEcCtD
Ipratropium bromide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.000885	CcSEcCtD
Ipratropium bromide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.000885	CcSEcCtD
Ipratropium bromide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.000885	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.000884	CcSEcCtD
Ipratropium bromide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000261	0.000882	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000261	0.000882	CcSEcCtD
Ipratropium bromide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.000881	CcSEcCtD
Ipratropium bromide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00088	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000879	CcSEcCtD
Ipratropium bromide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00026	0.000878	CcSEcCtD
Ipratropium bromide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000878	CcSEcCtD
Ipratropium bromide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.000875	CcSEcCtD
Ipratropium bromide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.000875	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000871	CcSEcCtD
Ipratropium bromide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000871	CcSEcCtD
Ipratropium bromide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000871	CcSEcCtD
Ipratropium bromide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.000871	CcSEcCtD
Ipratropium bromide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000257	0.00087	CcSEcCtD
Ipratropium bromide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.000869	CcSEcCtD
Ipratropium bromide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000257	0.000869	CcSEcCtD
Ipratropium bromide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.000867	CcSEcCtD
Ipratropium bromide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.000866	CcSEcCtD
Ipratropium bromide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000256	0.000865	CcSEcCtD
Ipratropium bromide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000863	CcSEcCtD
Ipratropium bromide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000863	CcSEcCtD
Ipratropium bromide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.000862	CcSEcCtD
Ipratropium bromide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.000858	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.000857	CcSEcCtD
Ipratropium bromide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000253	0.000856	CcSEcCtD
Ipratropium bromide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000252	0.000852	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.000851	CcSEcCtD
Ipratropium bromide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000252	0.000851	CcSEcCtD
Ipratropium bromide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000251	0.000848	CcSEcCtD
Ipratropium bromide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.000844	CcSEcCtD
Ipratropium bromide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.000843	CcSEcCtD
Ipratropium bromide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000249	0.000843	CcSEcCtD
Ipratropium bromide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000843	CcSEcCtD
Ipratropium bromide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000842	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000841	CcSEcCtD
Ipratropium bromide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000249	0.000841	CcSEcCtD
Ipratropium bromide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00084	CcSEcCtD
Ipratropium bromide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000249	0.00084	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.000839	CcSEcCtD
Ipratropium bromide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.000838	CcSEcCtD
Ipratropium bromide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000247	0.000835	CcSEcCtD
Ipratropium bromide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000247	0.000835	CcSEcCtD
Ipratropium bromide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000833	CcSEcCtD
Ipratropium bromide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000833	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.000833	CcSEcCtD
Ipratropium bromide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.000832	CcSEcCtD
Ipratropium bromide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000245	0.000828	CcSEcCtD
Ipratropium bromide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000245	0.000828	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000827	CcSEcCtD
Ipratropium bromide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000827	CcSEcCtD
Ipratropium bromide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000244	0.000823	CcSEcCtD
Ipratropium bromide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.000822	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.000821	CcSEcCtD
Ipratropium bromide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00082	CcSEcCtD
Ipratropium bromide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000243	0.00082	CcSEcCtD
Ipratropium bromide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000815	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.000811	CcSEcCtD
Ipratropium bromide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000811	CcSEcCtD
Ipratropium bromide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000809	CcSEcCtD
Ipratropium bromide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.000809	CcSEcCtD
Ipratropium bromide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.000805	CcSEcCtD
Ipratropium bromide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000804	CcSEcCtD
Ipratropium bromide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.000803	CcSEcCtD
Ipratropium bromide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.000801	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.0008	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000797	CcSEcCtD
Ipratropium bromide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.000795	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000235	0.000794	CcSEcCtD
Ipratropium bromide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.000793	CcSEcCtD
Ipratropium bromide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.000793	CcSEcCtD
Ipratropium bromide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000234	0.000792	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00079	CcSEcCtD
Ipratropium bromide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000785	CcSEcCtD
Ipratropium bromide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000232	0.00854	CbGeAlD
Ipratropium bromide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00078	CcSEcCtD
Ipratropium bromide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000779	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000778	CcSEcCtD
Ipratropium bromide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000777	CcSEcCtD
Ipratropium bromide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.000774	CcSEcCtD
Ipratropium bromide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000773	CcSEcCtD
Ipratropium bromide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000773	CcSEcCtD
Ipratropium bromide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000773	CcSEcCtD
Ipratropium bromide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000771	CcSEcCtD
Ipratropium bromide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000771	CcSEcCtD
Ipratropium bromide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000771	CcSEcCtD
Ipratropium bromide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00077	CcSEcCtD
Ipratropium bromide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000767	CcSEcCtD
Ipratropium bromide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.000764	CcSEcCtD
Ipratropium bromide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000226	0.000763	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000754	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00075	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000749	CcSEcCtD
Ipratropium bromide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000748	CcSEcCtD
Ipratropium bromide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000748	CcSEcCtD
Ipratropium bromide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000743	CcSEcCtD
Ipratropium bromide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000742	CcSEcCtD
Ipratropium bromide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000742	CcSEcCtD
Ipratropium bromide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000738	CcSEcCtD
Ipratropium bromide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000738	CcSEcCtD
Ipratropium bromide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000218	0.000737	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000737	CcSEcCtD
Ipratropium bromide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000736	CcSEcCtD
Ipratropium bromide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.000731	CcSEcCtD
Ipratropium bromide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.000731	CcSEcCtD
Ipratropium bromide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.00073	CcSEcCtD
Ipratropium bromide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000728	CcSEcCtD
Ipratropium bromide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.000726	CcSEcCtD
Ipratropium bromide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.000721	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000718	CcSEcCtD
Ipratropium bromide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000716	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000714	CcSEcCtD
Ipratropium bromide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000713	CcSEcCtD
Ipratropium bromide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000713	CcSEcCtD
Ipratropium bromide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000712	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000709	CcSEcCtD
Ipratropium bromide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000708	CcSEcCtD
Ipratropium bromide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000708	CcSEcCtD
Ipratropium bromide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000699	CcSEcCtD
Ipratropium bromide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000697	CcSEcCtD
Ipratropium bromide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000689	CcSEcCtD
Ipratropium bromide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000689	CcSEcCtD
Ipratropium bromide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.000689	CcSEcCtD
Ipratropium bromide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000686	CcSEcCtD
Ipratropium bromide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000203	0.000685	CcSEcCtD
Ipratropium bromide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000201	0.00068	CcSEcCtD
Ipratropium bromide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000679	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000677	CcSEcCtD
Ipratropium bromide—Headache—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000675	CcSEcCtD
Ipratropium bromide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000674	CcSEcCtD
Ipratropium bromide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000667	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000664	CcSEcCtD
Ipratropium bromide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000657	CcSEcCtD
Ipratropium bromide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000654	CcSEcCtD
Ipratropium bromide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000648	CcSEcCtD
Ipratropium bromide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000647	CcSEcCtD
Ipratropium bromide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000644	CcSEcCtD
Ipratropium bromide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000642	CcSEcCtD
Ipratropium bromide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000642	CcSEcCtD
Ipratropium bromide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000189	0.00064	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000639	CcSEcCtD
Ipratropium bromide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000638	CcSEcCtD
Ipratropium bromide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000638	CcSEcCtD
Ipratropium bromide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000622	CcSEcCtD
Ipratropium bromide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.00062	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000617	CcSEcCtD
Ipratropium bromide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000614	CcSEcCtD
Ipratropium bromide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000614	CcSEcCtD
Ipratropium bromide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000614	CcSEcCtD
Ipratropium bromide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000611	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.00061	CcSEcCtD
Ipratropium bromide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000605	CcSEcCtD
Ipratropium bromide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000596	CcSEcCtD
Ipratropium bromide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000594	CcSEcCtD
Ipratropium bromide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000593	CcSEcCtD
Ipratropium bromide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000585	CcSEcCtD
Ipratropium bromide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000579	CcSEcCtD
Ipratropium bromide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000574	CcSEcCtD
Ipratropium bromide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000573	CcSEcCtD
Ipratropium bromide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000568	CcSEcCtD
Ipratropium bromide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000568	CcSEcCtD
Ipratropium bromide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000566	CcSEcCtD
Ipratropium bromide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000565	CcSEcCtD
Ipratropium bromide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000551	CcSEcCtD
Ipratropium bromide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000547	CcSEcCtD
Ipratropium bromide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000547	CcSEcCtD
Ipratropium bromide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000546	CcSEcCtD
Ipratropium bromide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000543	CcSEcCtD
Ipratropium bromide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000535	CcSEcCtD
Ipratropium bromide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000526	CcSEcCtD
Ipratropium bromide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000522	CcSEcCtD
Ipratropium bromide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000521	CcSEcCtD
Ipratropium bromide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000518	CcSEcCtD
Ipratropium bromide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000515	CcSEcCtD
Ipratropium bromide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000492	CcSEcCtD
